# Single Dose Escalating Study of DAS181 in Adults

> **NCT00527865** · PHASE1 · COMPLETED · sponsor: **Ansun Biopharma, Inc.** · enrollment: 36 (estimated)

## Conditions studied

- Influenza

## Interventions

- **DRUG:** DAS181
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00527865
- **Lead sponsor:** Ansun Biopharma, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-10
- **Primary completion:** 2008-12
- **Final completion:** 2009-01
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2009-01-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00527865

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00527865, "Single Dose Escalating Study of DAS181 in Adults". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00527865. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*